Screening for drug activity in resistant cancer cell lines.

被引:0
|
作者
Rickardson, L [1 ]
Haglund, C [1 ]
Fryknäs, M [1 ]
Lövborg, H [1 ]
Nygren, P [1 ]
Gustafsson, MG [1 ]
Isaksson, A [1 ]
Larsson, R [1 ]
机构
[1] Univ Uppsala, S-75105 Uppsala, Sweden
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:8987S / 8987S
页数:1
相关论文
共 50 条
  • [1] Differential sensitivity to fas mediated apoptosis in drug resistant cell lines.
    Landowski, TH
    Guzman, MG
    Dalton, WS
    BLOOD, 1996, 88 (10) : 253 - 253
  • [2] Antimitotic agents with activity in multidrug-resistant tumor cell lines.
    Szczepankiewicz, BG
    Liu, G
    Tasker, AS
    Sorensen, BK
    von Geldern, TW
    Jae, HS
    Winn, M
    Gwaltney, SL
    Kester, JA
    Pei, ZH
    Wu-Wong, JR
    Gehrke, L
    Chiou, WJ
    Credo, RB
    Lee, JY
    Warner, RB
    Alder, JD
    Nukkala, MA
    Zielinski, NA
    Marsh, KC
    Rosenberg, SH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U25 - U25
  • [3] Molecular cytogenetic evaluation of MXR overexpression in drug resistant leukemia cell lines.
    Rao, VK
    Litman, T
    Eriksen, J
    Fojo, T
    Dean, M
    Skovsgaard, T
    BLOOD, 1999, 94 (10) : 282A - 282A
  • [4] Drug-resistant cell lines in cancer
    Cinatl Jr, Jindrich
    Wass, Mark N.
    Michaelis, Martin
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [5] The activity of 2′-benzoyloxycinnamaldehyde against drug-resistant cancer cell lines
    Chung, Young Min
    Do Yoo, Young
    Kim, Jun Suk
    Lee, Chang Youl
    Kim, Hyung Jung
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (04) : 428 - 437
  • [6] Synergistic interactions of disulfiram, BSO and arsenic trioxide on drug resistant melanoma cell lines.
    Fruehauf, John P.
    Meyskens, Frank
    CANCER RESEARCH, 2006, 66 (08)
  • [7] The construction of drug-resistant cancer cell lines by CRISPR/Cas9 system for drug screening
    Lingmin Zhang
    Ying Li
    Qinghua Chen
    Yong Xia
    Wenfu Zheng
    Xingyu Jiang
    Science Bulletin, 2018, 63 (21) : 1411 - 1419
  • [8] The construction of drug-resistant cancer cell lines by CRISPR/Cas9 system for drug screening
    Zhang, Lingmin
    Li, Ying
    Chen, Qinghua
    Xia, Yong
    Zheng, Wenfu
    Jiang, Xingyu
    SCIENCE BULLETIN, 2018, 63 (21) : 1411 - 1419
  • [9] Activity of CRE-decoy oligonucleotides in colorectal cancer cell lines.
    Liu, WM
    Scott, KA
    Joel, SP
    Propper, DJ
    BRITISH JOURNAL OF CANCER, 2002, 86 : S17 - S17
  • [10] Novel drug discovery by pharmacogenomic profiling of 36 colorectal cancer cell lines.
    Eide, Peter
    Bruun, Jarle
    Sveen, Anita
    MurumAfagi, Astrid
    Mpindi, John
    Arjama, Mariliina
    Kallioniemi, Olli
    Lothe, Ragnhild A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)